BashirS,PoornimaR,,2016,Pharmacogenetic variations related to clopidogrel resistance and its clinical implications: An issue which remains largely unaddressed,Asian J Pharm Clin Res,9,194-6
GallottaA,MarengoniA,PasinaL,CortesiL,NobiliA,,2017,Prevalence of older in-patients at risk of clopidogrel resistance according to the STIB score. Results from REPOSI registry,Eur J Intern Med,41,e17-8
WuZK,WangJJ,WangT,ZhuSS,ChenXL,LiuC,,2015,Clopidogrel resistance response in patients with coronary artery disease and metabolic syndrome: the role of hyperglycemia and obesity,J Geriatr Cardiol,12,378-82
WangZJ,ZhouYJ,LiuYY,YuM,ShiDM,ZhaoYX,,2009,Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent,Thromb Res,124,46-51
CuiG,ZhangS,ZouJ,ChenY,ChenH.,,2017,P2Y12 receptor gene polymorphism and the risk of resistance to clopidogrel: A metaanalysis and review of the literature,Adv Clin Exp Med,26,343-9
Bonello-PalotN,ArmeroS,PaganelliF,ManciniJ,De LabriolleA,BonelloC,,2009,Relation of body mass index to high ontreatment platelet reactivity and of failed clopidogrel dose adjustment according to platelet reactivity monitoring in patients undergoing percutaneous coronary intervention,Am J Cardiol,104,1511-5
Al-AzzamSI,AlzoubiKH,KhabourOF,NusairMB,Al-HadidiH,AwidiA,,2013,Factors that contribute to clopidogrel resistance in cardiovascular disease patients: environmental and genetic approach,Int J Clin Pharmacol Ther,51,179-86
ShetkarSS,RamakrishnanS,SethS,ChandnaP,VermaSK,BhargavaB,,2014,CYP 450 2C19 polymorphisms in Indian patients with coronary artery disease,Indian Heart J,66,16-24
ShaliaKK,ShahVK,PawarP,DivekarSS,PayannavarS.,,2013,Polymorphisms of MDR1, CYP2C19 and P2Y12 genes in Indian population: Effects on clopidogrel response,Indian Heart J,65,158-67
HumayunA,ShahAS,AlamS,HusseinH,,2009,Relationship of body mass index and dyslipidemia in different age groups of male and female population of Peshawar,J Ayub Med Coll Abbottabad,21,141-4
AngiolilloDJ,Fernandez-OrtizA,BernardoE,RamírezC,SabatéM,Jimenez-QuevedoP,,2005,Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment,Diabetes,54,2430-5
GurbelPA,TantryUS,,2007,,Clopidogrel resistance? Thromb Res,120,311-21
,2006,Profile and prevalence of clopidogrel resistance in patients of acute coronary syndrome,Indian Heart J,59,152-6
BlidenKP,DiChiaraJ,TantryUS,BassiAK,ChagantiSK,GurbelPA,,2007,Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention,J Am Coll Cardiol,49,657-66
PengFei,,2017,Analysis of clopidogrel resistance and its influencing factors in patients with ischemic stroke and transient ischemic attack,Chinese J Clin Neurosci,3,10-
FeherG,KoltaiK,AlkonyiB,PappE,KeszthelyiZ,KesmarkyG,,2007,Clopidogrel resistance: role of body mass and concomitant medications,Int J Cardiol,120,188-92
WangL,WangX,ChenF,,2010,Clopidogrel resistance is associated with long-term thrombotic events in patients implanted with drug-eluting stents,Drugs in R & D,10,219-24
DentaliF,SquizzatoA,AgenoW.,,2009,The metabolic syndrome as a risk factor for venous and arterial thrombosis,Semin Thromb Hemost,35,451-7
,2005,Hypercoagulability in the metabolic syndrome,Curr Opin Pharmacol,5,155-9
AnfossiG,RussoI,TrovatiM.,,2009,Platelet dysfunction in central obesity,Nutr Metab Cardiovasc Dis,19,440-9
KonstantinidesS,SchäferK,KoschnickS,LoskutoffDJ,,2001,Leptindependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity,J Clin Invest,108,1533-40
DavìG,GuagnanoMT,CiabattoniG,BasiliS,FalcoA,MarinopiccoliM,,2002,Platelet activation in obese women: role of inflammation and oxidant stress,JAMA,288,2008-14